When MS tissue samples were analyzed, we observed a significantly reduced number of NOGOA-positive oligodendrocytes expressing NFATc4 in active demyelinating and post-demyelinating lesions compared to control and periplaque white matter where the vast majority of oligodendrocytes expressed NFATc4. The gene discussed is NFATC4; the disease is myeloid sarcoma.